Ultrastructural immunocytochemistry of collagenous and non-collagenous proteins in fast-frozen, freeze-substituted, and low-temperature-embedded renal tissue in Alport syndrome

Journal of Pathology

Volumn 182, Issue 4, 1997, Pages 465-474

  Muda, Andrea Onetti ^a   Rahimi, Siavash ^b   Renieri, Alessandra ^c   Rizzoni, Gianfranco ^d   Massella, Laura ^d   Faraggiana, Tullio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

2(IV); Alport syndrome; glomerulosclerosis; immunoelectron microscopy; kidney; laminin; N Pro I

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; LAMININ; PROTEIN;

ADOLESCENT; ALPORT SYNDROME; ARTICLE; CASE REPORT; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL;

BASEMENT MEMBRANE; CHILD; CHILD, PRESCHOOL; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; FREEZE SUBSTITUTION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY GLOMERULUS; LAMININ; MALE; MICROSCOPY, IMMUNOELECTRON; NEPHRITIS, HEREDITARY; TISSUE EMBEDDING;

EID: 0030838424     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199708)182:4<465::AID-PATH465>3.0.CO;2-V     Document Type: Article

References (46)

1. Tryggvason K, Zhou J, Hostikka SL. Shows TB. Molecular genetics of Alport syndrome. Kidney Int 1993; 43: 38-44.
2. Sessa A, Renieri A, Battaglia C. Alport syndrome: clinical, molecular and genetic aspects. J Nephrol 1994; 7: 102-114.
3. Alport AC. Hereditary familial congenital haemorrhagic nephritis. Br Med J 1927; 1: 504-506.
4. Hinglais N, Grunfeld SP, Bois E. Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome). Lab Invest 1972; 27: 473-487.
5. Churg J, Sherman RL. Pathological characteristics of hereditary nephritis. Arch Pathol 1973; 95: 374-379.
6. Brunner H, Schroeder C, Van Bennekom C, et al. Localization of the gene for X-linked Alport's syndrome. Kidney Int 1988; 34: 507-510.
7. Atkin CL, Hesstedt SS, Menlove L, et al. Mapping of Alport syndrome to the long arm of the X chromosome. Am J Hum Genet 1988; 42: 249-255.
8. Flinter FA, Abbs S, Bobrow M. Localization of the gene for classic Alport syndrome. Genomics 1989; 4: 335-338.
9. Feingold J, Bois E, Chompet A, Broyer M, Gubler MC, Grünfeld JP. Genetic heterogeneity of Alport syndrome. Kidney Int 1985; 27: 672-677.
10. Hostikka SL, Eddy RL, Byers MG, Höyhtyä M, Shows TB, Tryggvason K. Identification of a distinct type IV collagen α chain with restricted kidney distribution and assignment of the gene to the locus on X-linked Alport syndrome. Proc Natl Acad Sci USA 1990; 87: 1606-1610.
11. Zhou J, Leinonen A, Tryggvason KS. Structure of the human type IV collagen COL4A5 gene. J Biol Chem 1994; 269: 6608-6614.
12. Zhou J, Hertz JM, Leinonen A, Tryggvason K. Complete amino acid sequence of the human α5(IV) collagen chain and identification of a single-base mutation in exon 23 converting glycine 521 in the collagenous domain to cysteine in Alport syndrome patient. J Biol Chem 1992; 267: 12475-12481.
13. Barker DF, Hostikka SL, Zhou J, et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990; 248: 1224-1227.
14. Boye E, Vetrie D, Flinter F, et al. Major rearrangements in the α5(IV) collagen gene in three patients with Alport syndrome. Genomics 1991; 11: 1125-1132.
15. Smeets HJ, Melenhorst JJ, Lemmink HH, et al. Different mutations in the COL4A5 collagen gene in two patients with different features of Alport syndrome. Kidney Int 1992; 42: 83-88.
16. Renieri A, Seri M, Myers JC, et al. Alport syndrome caused by a 5′ deletion within the COL4A5 gene. Hum Genet 1992; 89: 120-121.
17. Netzer K, Renders L, Zhou J, Pullig O, Tryggvason K, Weber M. Deletions of the COL4A5 gene in patients with Alport syndrome. Kidney Int 1992; 42: 1336-1344.
18. Zhou J, Barker DF, Hostikka SL, Gregory M, Atkin CL, Tryggvason K. Single base mutation in α5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. Genomics 1991; 9: 10-18.
19. Netzer KO, Pullig O, Frei U, Zhou J, Tryggvason K, Weber M. COL4A5 splice site mutation and α5(IV) collagen mRNA in Alport syndrome. Kidney Int 1993; 43: 486-492.
20. Nakazato H, Hattori S, Matsuura T, Koitabashi Y, Endo F, Matsuda I. Identification of a single base insertion in the COL4A5 gene in Alport syndrome. Kidney Int 1993; 44: 1091-1096.
21. Naito I, Kawai S, Nomura S, et al. Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome. Kidney Int 1996; 50: 304-311.
22. Mariyama M, Zheng K, Yeng-Feng TL, Reeders ST. Colocalization of the genes for the α3(IV) and α4(IV) chains of type IV collagen to chromosome 2 bands q35-q37. Genomics 1992; 13: 809-813.
23. Kashtan CE, Kim Y. Distribution of the α1 and α2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 1992; 42: 115-126.
24. Kim KH, Kim Y, Gubler MC, et al. Structural-functional relationships in Alport syndrome. J Am Soc Nephrol 1995; 5: 1659-1668.
25. Neri T, Zanelli P, Savi M, et al. Heterogeneity of COL4A5 mutations in Alport patients: update of the Italian Multicenter Study. XXVII Annual Meeting of the European Society of Human Genetics, Berlin, 23-27 May 1995; 271 (Abstract).
26. Monaghan P, Robertson D. Freeze-substitution without aldehyde or osmium fixatives: ultrastructure and implications for immunocytochemistry. J Microsc 1990; 158: 355-363.
27. Von Schack ML, Fakan S, Villiger W, Müller M. Cryofixation and cryosubstitution: a useful alternative in the analyses of cellular fine structure. Eur J Histochem 1993; 37: 5-18.
28. Timpl R, Wiedemann H, Van Delden V, Furthmayr H, Kuhn K. A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 1981; 120: 203-211.
29. Johansson C, Butkowski RJ, Wieslander J. The structural organization of type IV collagen. Identification of three NC1 populations in the glomerular basement membrane. J Biol Chem 1992; 267: 24533-24537.
30. Zhou J, Mochizuki T, Smeets H, et al. Deletion of the paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors. Science 1993; 261: 1167-1169.
31. Zhou J, Ding M, Zhao Z, Reeders ST. Complete primary structure of the sixth chain of human basement membrane collagen, alpha 6(IV). Isolation of the cDNAs for alpha 6(IV) and comparison with five other type IV collagen chains. J Biol Chem 1994; 269: 13193-13199.
32. Oohashi T, Sugimoto M, Mattei MG, Ninomiya Y. Identification of a new collagen IV chain, alpha 6(IV), by cDNA isolation and assignment of the gene to chromosome Xq22, which is the same locus for COL4A5. J Biol Chem 1994; 269: 7520-7526.
33. Zhu D, Kim Y, Steffes MW, Groppoli TJ, Butkowski RJ, Mauer SM. Application of electron microscopic immunocytochemistry to the human kidney: distribution of type IV and type VI collagen in normal human kidney. J Histochem Cytochem 1994; 42: 577-584.
34. Cai Y, Sich M, Beziau A, Kleppel MM, Gubler MC. Collagen distribution in focal and segmental glomerulosclerosis: an immunofluorescence and ultrastructural immunogold study. J Pathol 1996; 179: 188-196.
35. Hirata K, Shikata K, Makino H, Hayashi T, Ota Z. Immunohistological localization of the novel epitope related to the type IV collagen in normal and diseased renal tissues. J Pathol 1995; 177: 407-413.
36. Hudson BG, Reeders ST, Tryggvason K. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 1993; 268: 26033-26036.
37. Butkowski RJ, Wieslander J, Kleppel M, Michael AF, Fish AJ. Basement membrane collagen in the kidney: regional localization of novel chains related to collagen IV. Kidney Int 1989; 35: 1195-1202.
38. Kleppel M, Santi PA, Cameron J, Wieslander J, Michael AF. Human tissue distribution of novel basement membrane collagen. Am J Pathol 1989; 134: 813-825.
39. Yoshioka K, Hino S, Takemura T, et al. Type IV collagen α5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 1994; 144: 986-996.
40. Ninomiya Y, Iyama K, Kagawa M, Sugimoto M, Oohashi T, Sado Y. Differential localization of α6(IV) and α5(IV) collagen chains in basement membranes. In: XIV Meeting of the European Connective Tissue Societies (Abstract book). Lyon, 1994; K18.
41. Sheinman J, Tanaka H, Haralson M, Wang S, Brown O. Specialized collagen mRNA and secreted collagens in human glomerular epithelial, mesangial and tubular cells. JASN 1992; 2: 1475-1483.
42. Razzaque MS, Koji T, Kawano H, Harada T, Nakane PK, Taguchi T. Glomerular expression of type III and type IV collagens in benign nephrosclerosis: immunohistochemical and in situ hybridization study. Pathol Res Pract 1994; 190: 493-499.
43. Glick AD, Jacobson HR, Haralson MA. Mesangial deposition of type I collagen in human glomerulosclerosis. Hum Pathol 1992; 23: 1373-1379.
44. Büyükbabani N, Droz D. Distribution of the extracellular matrix components in human glomerular lesions. J Pathol 1994; 172: 199-207.
45. Hulmes DJS. Mechanism for the regulation of collagen fibril diameter in vivo. Coll Rel Res 1983; 3: 317-321.
46. Fleischmajer R, Perlish JS. The role of amino propeptide in collagen fibrillogenesis. Rheumatology 1986; 10: 91-103.